“Is Pfizer an Excellent Dividend Stock to Buy? | PFE Stock Analysis”
Pfizer is a buy; DCF fair value of $50 implies significant upside from current levels.
Pfizer's management team is already incorporating artificial intelligence to help accelerate drug discovery, which is one of the biggest bullish opportunities that I see with artificial intelligence in the total opportunity value it can add to humanity worldwide.
They're also using artificial intelligence to help optimize manufacturing yields and enhance the effectiveness of its commercial sales force, but I think the bigger opportunity is in drug discovery with these pharmaceutical companies.